These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9328174

  • 1. Improved 32P-postlabelling assay for the quantification of the major platinum-DNA adducts.
    Welters MJ, Maliepaard M, Jacobs-Bergmans AJ, Baan RA, Schellens JH, Ma J, van der Vijgh WJ, Braakhuis BJ, Fichtinger-Schepman AM.
    Carcinogenesis; 1997 Sep; 18(9):1767-74. PubMed ID: 9328174
    [Abstract] [Full Text] [Related]

  • 2. Detection of platinum-DNA adducts by 32P-postlabelling.
    Blommaert FA, Saris CP.
    Nucleic Acids Res; 1995 Apr 25; 23(8):1300-6. PubMed ID: 7753620
    [Abstract] [Full Text] [Related]

  • 3. 32P-postlabeling assay for the quantification of the major platinum-DNA adducts.
    Pluim D, Maliepaard M, van Waardenburg RC, Beijnen JH, Schellens JH.
    Anal Biochem; 1999 Nov 01; 275(1):30-8. PubMed ID: 10542106
    [Abstract] [Full Text] [Related]

  • 4. In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells.
    Saris CP, van de Vaart PJ, Rietbroek RC, Blommaert FA.
    Carcinogenesis; 1996 Dec 01; 17(12):2763-9. PubMed ID: 9006117
    [Abstract] [Full Text] [Related]

  • 5. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF, Le Pla RC, Jones GD, Thomas AL, Farmer PB.
    Chem Res Toxicol; 2010 Aug 16; 23(8):1313-21. PubMed ID: 20666396
    [Abstract] [Full Text] [Related]

  • 6. Comparison of TLC- and HPLC-32P-postlabelling assay for cisplatin-DNA adducts.
    Försti A, Staffas J, Hemminki K.
    Carcinogenesis; 1994 Dec 16; 15(12):2829-34. PubMed ID: 8001242
    [Abstract] [Full Text] [Related]

  • 7. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A, Apostoli P, Zaninelli M, Pavanel F, Colombatti M, Cetto GL, Franceschi T, Sperotto L, Leone R.
    Clin Cancer Res; 1996 Nov 16; 2(11):1829-35. PubMed ID: 9816137
    [Abstract] [Full Text] [Related]

  • 8. Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.
    Kovács K, Anna L, Rudnai P, Schoket B.
    Mutat Res; 2011 Mar 18; 721(1):95-100. PubMed ID: 21237286
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the DNA damage recognized by an antiserum elicited against cis-diamminedichloroplatinum (II)-modified DNA.
    Reed E, Gupta-Burt S, Litterst CL, Poirier MC.
    Carcinogenesis; 1990 Dec 18; 11(12):2117-21. PubMed ID: 1979937
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.
    Johnsson A, Olsson C, Nygren O, Nilsson M, Seiving B, Cavallin-Stahl E.
    Cancer Chemother Pharmacol; 1995 Dec 18; 37(1-2):23-31. PubMed ID: 7497593
    [Abstract] [Full Text] [Related]

  • 11. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques.
    Plooy AC, Fichtinger-Schepman AM, Schutte HH, van Dijk M, Lohman PH.
    Carcinogenesis; 1985 Apr 18; 6(4):561-6. PubMed ID: 4039227
    [Abstract] [Full Text] [Related]

  • 12. Cisplatin DNA adduct detection and depurination measured by 32P DNA radiolabeling and two-dimensional thin-layer chromatography: a time and concentration study.
    Farah N, Dresner HS, Searles KJ, Winiarsky R, Moosikasuwan M, Cajigas A, Hahm S, Steinberg JJ.
    Cancer Invest; 2000 Apr 18; 18(4):314-26. PubMed ID: 10808367
    [Abstract] [Full Text] [Related]

  • 13. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
    Meerum Terwogt JM, Groenewegen G, Pluim D, Maliepaard M, Tibben MM, Huisman A, ten Bokkel Huinink WW, Schot M, Welbank H, Voest EE, Beijnen JH, Schellens JM.
    Cancer Chemother Pharmacol; 2002 Mar 18; 49(3):201-10. PubMed ID: 11935212
    [Abstract] [Full Text] [Related]

  • 14. 32P-postlabelling method for the detection of 7-alkylguanine adducts formed by the reaction of different 1,2-alkyl epoxides with DNA.
    Kumar R, Staffas J, Försti A, Hemminki K.
    Carcinogenesis; 1995 Mar 18; 16(3):483-9. PubMed ID: 7697802
    [Abstract] [Full Text] [Related]

  • 15. 32P-postlabelling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans.
    Talaska G, Roh JH, Getek T.
    J Chromatogr; 1992 Sep 16; 580(1-2):293-323. PubMed ID: 1400827
    [Abstract] [Full Text] [Related]

  • 16. Influence of the degree of DNA modification on the immunochemical determination of cisplatin-DNA adduct levels.
    Fichtinger-Schepman AM, Baan RA, Berends F.
    Carcinogenesis; 1989 Dec 16; 10(12):2367-9. PubMed ID: 2591026
    [Abstract] [Full Text] [Related]

  • 17. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K, Liehr JG, Gladek A, Randerath E.
    IARC Sci Publ; 1989 Dec 16; (96):189-205. PubMed ID: 2509347
    [Abstract] [Full Text] [Related]

  • 18. Detection and characterization of carcinogen-DNA adducts in exfoliated urothelial cells from 4-aminobiphenyl-treated dogs by 32P-postlabelling and subsequent thin-layer and high-pressure liquid chromatography.
    Talaska G, Dooley KL, Kadlubar FF.
    Carcinogenesis; 1990 Apr 16; 11(4):639-46. PubMed ID: 2323002
    [Abstract] [Full Text] [Related]

  • 19. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
    Yamada K, Kato N, Takagi A, Koi M, Hemmi H.
    Anal Bioanal Chem; 2005 Aug 16; 382(7):1702-7. PubMed ID: 15959768
    [Abstract] [Full Text] [Related]

  • 20. Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.
    Fichtinger-Schepman AM, Vendrik CP, van Dijk-Knijnenburg WC, de Jong WH, van der Minnen AC, Claessen AM, van der Velde-Visser SD, de Groot G, Wubs KL, Steerenberg PA.
    Cancer Res; 1989 Jun 01; 49(11):2862-7. PubMed ID: 2720647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.